Literature DB >> 24741047

Biphasic mechanisms of amphetamine action at the dopamine terminal.

Cody A Siciliano1, Erin S Calipari, Mark J Ferris, Sara R Jones.   

Abstract

In light of recent studies suggesting that amphetamine (AMPH) increases electrically evoked dopamine release ([DA]o), we examined discrepancies between these findings and literature that has demonstrated AMPH-induced decreases in [DA]o. The current study has expanded the inventory of AMPH actions by defining two separate mechanisms of AMPH effects on [DA]o at high and low doses, one dopamine transporter (DAT) independent and one DAT dependent, respectively. AMPH concentrations were measured via microdialysis in rat nucleus accumbens after intraperitoneal injections of 1 and 10 mg/kg and yielded values of ∼10 and 200 nM, respectively. Subsequently, voltammetry in brain slices was used to examine the effects of low (10 nM), moderate (100 nM), and high (10 μM) concentrations of AMPH across a range of frequency stimulations (one pulse; five pulses, 20 Hz; 24 pulses, 60 Hz). We discovered biphasic, concentration-dependent effects in WT mice, in which AMPH increased [DA]o at low concentrations and decreased [DA]o at high concentrations across all stimulation types. However, in slices from DAT-KO mice, [DA]o was decreased by all concentrations of AMPH, demonstrating that AMPH-induced increases in [DA]o are DAT dependent, whereas the decreases at high concentrations are DAT independent. We propose that low AMPH concentrations are insufficient to disrupt vesicular sequestration, and therefore AMPH acts solely as a DAT inhibitor to increase [DA]o. When AMPH concentrations are high, the added mechanism of vesicular depletion leads to reduced [DA]o. The biphasic mechanisms observed here confirm and extend the traditional actions of AMPH, but do not support mechanisms involving increased exocytotic release.

Entities:  

Keywords:  dopamine transporter; knock-out; nucleus accumbens; phasic; tonic; voltammetry

Mesh:

Substances:

Year:  2014        PMID: 24741047      PMCID: PMC3988413          DOI: 10.1523/JNEUROSCI.4050-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  29 in total

1.  Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action.

Authors:  D Sulzer; S Rayport
Journal:  Neuron       Date:  1990-12       Impact factor: 17.173

2.  Mechanism of amphetamine accumulation in the isolated perfused heart of the rat.

Authors:  H Thoenen; A Hürlimann; W Haefely
Journal:  J Pharm Pharmacol       Date:  1968-01       Impact factor: 3.765

3.  Dopamine and noradrenaline transport into subcellular vesicles of the striatum.

Authors:  A Philippu; J Beyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

5.  Dopamine neuronal transport kinetics and effects of amphetamine.

Authors:  S R Jones; J D Joseph; L S Barak; M G Caron; R M Wightman
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

6.  Acute administration of d-amphetamine decreases impulsivity in healthy volunteers.

Authors:  Harriet de Wit; Justin L Enggasser; Jerry B Richards
Journal:  Neuropsychopharmacology       Date:  2002-11       Impact factor: 7.853

7.  Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine.

Authors:  N Y Liang; C O Rutledge
Journal:  Biochem Pharmacol       Date:  1982-03-15       Impact factor: 5.858

8.  Disposition of (-)-fenfluramine and its active metabolite, (-)-norfenfluramine in rat: a single dose-proportionality study.

Authors:  R Spinelli; C Fracasso; G Guiso; S Garattini; S Caccia
Journal:  Xenobiotica       Date:  1988-05       Impact factor: 1.908

9.  The transport of (+)-amphetamine by the neuronal noradrenaline carrier.

Authors:  H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

Review 10.  Monoamine transporters and psychostimulant drugs.

Authors:  Richard B Rothman; Michael H Baumann
Journal:  Eur J Pharmacol       Date:  2003-10-31       Impact factor: 4.432

View more
  34 in total

1.  Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter.

Authors:  Molly M McGinnis; Cody A Siciliano; Sara R Jones
Journal:  J Neurochem       Date:  2016-08-15       Impact factor: 5.372

2.  Voluntary ethanol intake predicts κ-opioid receptor supersensitivity and regionally distinct dopaminergic adaptations in macaques.

Authors:  Cody A Siciliano; Erin S Calipari; Verginia C Cuzon Carlson; Christa M Helms; David M Lovinger; Kathleen A Grant; Sara R Jones
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

3.  Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users.

Authors:  Isabelle Boileau; Doris Payer; Pablo M Rusjan; Sylvain Houle; Junchao Tong; Tina McCluskey; Alan A Wilson; Stephen J Kish
Journal:  Neuropsychopharmacology       Date:  2016-06-29       Impact factor: 7.853

4.  Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway.

Authors:  David M Hedges; J Daniel Obray; Jordan T Yorgason; Eun Young Jang; Vajira K Weerasekara; Joachim D Uys; Frederick P Bellinger; Scott C Steffensen
Journal:  Neuropsychopharmacology       Date:  2017-11-29       Impact factor: 7.853

5.  Amphetamine potency varies with dopamine uptake rate across striatal subregions.

Authors:  Cody A Siciliano; Erin S Calipari; Sara R Jones
Journal:  J Neurochem       Date:  2014-07-30       Impact factor: 5.372

6.  α6β2 subunit containing nicotinic acetylcholine receptors exert opposing actions on rapid dopamine signaling in the nucleus accumbens of rats with high-versus low-response to novelty.

Authors:  Cody A Siciliano; J Michael McIntosh; Sara R Jones; Mark J Ferris
Journal:  Neuropharmacology       Date:  2017-06-27       Impact factor: 5.250

7.  Electrochemical Measurements of Acetylcholine-Stimulated Dopamine Release in Adult Drosophila melanogaster Brains.

Authors:  Mimi Shin; B Jill Venton
Journal:  Anal Chem       Date:  2018-08-16       Impact factor: 6.986

8.  Amphetamine enantiomers inhibit homomeric α7 nicotinic receptor through a competitive mechanism and within the intoxication levels in humans.

Authors:  Daniel R Garton; Sharmaine G Ross; Rafael Maldonado-Hernández; Matthias Quick; José A Lasalde-Dominicci; José E Lizardi-Ortiz
Journal:  Neuropharmacology       Date:  2018-10-23       Impact factor: 5.250

9.  Individual variation in incentive salience attribution and accumbens dopamine transporter expression and function.

Authors:  Bryan F Singer; Bipasha Guptaroy; Curtis J Austin; Isabella Wohl; Vedran Lovic; Jillian L Seiler; Roxanne A Vaughan; Margaret E Gnegy; Terry E Robinson; Brandon J Aragona
Journal:  Eur J Neurosci       Date:  2016-01-07       Impact factor: 3.386

10.  Cocaine Self-Administration Produces Long-Lasting Alterations in Dopamine Transporter Responses to Cocaine.

Authors:  Cody A Siciliano; Steve C Fordahl; Sara R Jones
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.